NASDAQ: CVRXCvrx Inc Stock Ownership - Who owns Cvrx?
Insider buying vs selling
Have Cvrx Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Brent Binkowski | COO | 2026-08-13 | 26,223 | $2.92 | $76.44kBuy |
| Brent Binkowski | COO | 2026-08-12 | 1,309 | $2.55 | $3.34kSell |
| Philip B. Adamson | Chief Medical Officer | 2026-03-02 | 1,262 | $7.90 | $9.97kSell |
| Kevin Hykes | PRES CEO | 2026-03-02 | 7,763 | $7.90 | $61.35kSell |
| Robert Allen John | Chief Revenue Officer | 2026-03-02 | 3,964 | $7.90 | $31.32kSell |
| Jared Oasheim | CHIEF FINANCIAL OFFICER | 2026-03-02 | 1,744 | $7.90 | $13.78kSell |
| Paul Verrastro | CHIEF MKTG STRAT OFFICER | 2026-03-02 | 1,284 | $7.90 | $10.15kSell |
| Mudit K. Jain | Director | 2026-02-20 | 46,800 | $6.36 | $297.60kBuy |
| Mudit K. Jain | Director | 2026-02-18 | 600 | $4.64 | $2.79kBuy |
| Johnson Johnson | 10% Owner | 2025-11-26 | 6,337 | $10.03 | $63.56kSell |
CVRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when CVRX insiders and whales buy or sell their stock.
CVRX Shareholders
What type of owners hold Cvrx Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Johnson Johnson | 28.23% | 7,520,436 | $22.86M | Insider |
| Johnson Innovatio Johnson | 13.12% | 3,495,575 | $10.63M | Insider |
| Nea Partners 10 L P | 8.26% | 2,200,855 | $6.69M | Insider |
| New Enterprise Associates 10 L P | 7.60% | 2,026,083 | $6.16M | Insider |
| Kirk G. Nielsen | 7.20% | 1,918,854 | $5.83M | Insider |
| Geoffrey B. Pardo | 6.87% | 1,829,022 | $5.56M | Insider |
| Glaxosmithkline PLC | 3.78% | 1,007,583 | $3.06M | Insider |
| Mudit K. Jain | 3.73% | 994,553 | $3.02M | Insider |
| Kevin Hykes | 1.07% | 284,237 | $864.08k | Insider |
| Jared Oasheim | 0.36% | 96,703 | $293.98k | Insider |
CVRX vs Medical Device Stocks
Cvrx Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.